Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 7/20 | 1.00 |
| ▸ | HSD17B3 | P37058 | 5/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.68 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.68 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.68 |
| ▸ | GPBAR1 | Q8TDU6 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | SHBG | P04278 | 2/20 | 0.65 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.65 |
| ▸ | G6PD | P11413 | 1/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5925374 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL12825203 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL1552239 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL1650324 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL17817126 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL1908291 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL10273218 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL12370187 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL20714758 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 | |
| SCHEMBL12178030 | 1.00 | CYP19A1 (1.00) | CYP19A1HSD17B3AKR1B10AKR1B1OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160251391-A9 | NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-09-01 | — | — | US | disclosed |
| US-20150361125-A1 | NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS | UNIV WASHINGTON (US) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361125-A1 | NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS | GABRA4, GABRA5, GABRA3 | CYP19A1 300/4885HSD17B3 139/4885AKR1B10 656/4885 |
| US-20160251391-A9 | NEUROACTIVE ENANTIOMERIC 15-, 16- AND 17-SUBSTITUTED STEROIDS AS MODULATORS FOR GABA TYPE-A RECEPTORS | GABRA4, GABRA5, GABRA3 | CYP19A1 300/4885HSD17B3 139/4885AKR1B10 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.